NYU Langone Ambulatory Care Brooklyn Heights
Brooklyn, New York, United States
Medical clinic in Brooklyn, New York
186 Joralemon St, Brooklyn, NY 11201
About NYU Langone Ambulatory Care Brooklyn Heights
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bristol-Myers Squibb
3
Janssen Research & Development, LLC
3
Pfizer
2
R-Pharm International, LLC
2
Eli Lilly and Company
1
Galapagos NV
1
Horizon Therapeutics Ireland DAC
1
Novartis Pharmaceuticals
1
Viela Bio (acquired by Horizon Therapeutics)
1
Clinical Trials at NYU Langone Ambulatory Care Brooklyn Heights
During the past decade, NYU Langone Ambulatory Care Brooklyn Heights conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
2015-07-21
2019-02-27
Completed
3,021
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
2016-05-24
2019-11-05
Completed
1,648
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
2017-02-28
2025-05-01
Active, not recruiting
2,731
Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
2017-07-04
2021-09-01
Completed
2,106
A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
2019-04-18
2023-10-06
Active, not recruiting
347
Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
2020-07-07
2026-01-08
Recruiting
400
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
2020-01-07
2022-12-05
Completed
112
A Study of Guselkumab in Participants With Active Lupus Nephritis
2020-09-15
2023-02-01
Completed
33
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NYU Langone Ambulatory Care Brooklyn Heights" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials
sponsored, "Pfizer" with 2 trials sponsored, "R-Pharm International, LLC" with 2 trials sponsored and "Eli Lilly and Company"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Ambulatory Care Brooklyn Heights"
#1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at NYU Langone Ambulatory Care Brooklyn Heights
According to Clinical.Site data, the most researched conditions in "NYU Langone Ambulatory Care Brooklyn Heights" are
"Rheumatoid Arthritis" (6 trials), "Systemic Lupus Erythematosus" (4 trials), "Arthritis, Psoriatic" (2 trials), "Lupus Nephritis" (2 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "NYU Langone Ambulatory Care Brooklyn Heights" in a lesser frequency.
Clinical Trials Intervention Types at NYU Langone Ambulatory Care Brooklyn Heights
Most popular intervention types in "NYU Langone Ambulatory Care Brooklyn Heights" are "Drug" (14 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Guselkumab" (2 trials), "Abatacept" (1 trials), "Adalimumab" (1 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NYU Langone Ambulatory Care Brooklyn Heights
The vast majority of trials in "NYU Langone Ambulatory Care Brooklyn Heights" are
15 trials for "All" genders.
Clinical Trials Status at NYU Langone Ambulatory Care Brooklyn Heights
Currently, there are NaN active trials in "NYU Langone Ambulatory Care Brooklyn Heights".
undefined are not yet recruiting,
5 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 5 completed trials in NYU Langone Ambulatory Care Brooklyn Heights,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NYU Langone Ambulatory Care Brooklyn Heights, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".